How to Get Low-Dose Naltrexone in South Carolina

What Is Low-Dose Naltrexone and Why Is It Compounded?

Low-dose naltrexone (LDN) refers to naltrexone hydrochloride prescribed at 1.5 mg to 4.5 mg per day, a fraction of the FDA-approved 50 mg dose used for opioid and alcohol use disorders 1. At these low doses, naltrexone is thought to produce a brief, transient blockade of opioid receptors that triggers an upregulation of endogenous endorphins and modulates microglial cell activity in the central nervous system 2.

Because no manufacturer markets a 1.5 mg or 4.5 mg tablet, LDN must be prepared by a compounding pharmacy. In South Carolina, 503A compounding pharmacies licensed by the SC Board of Pharmacy are authorized to fill patient-specific LDN prescriptions. This is a key distinction. You cannot walk into a CVS or Walgreens and pick up LDN off the shelf.

The FDA has not approved naltrexone at low doses for any indication. All LDN prescribing is off-label. That does not mean it is unregulated. The prescriber must hold an active license in South Carolina, and the compounding pharmacy must comply with USP <795> standards for non-sterile preparations 3.

Who Can Prescribe LDN in South Carolina?

Any clinician with prescriptive authority under South Carolina law can write an LDN prescription. That includes physicians (MD and DO), nurse practitioners (NP), and physician assistants (PA). NPs in South Carolina practice under a collaborative agreement with a physician, but this does not prevent them from prescribing off-label medications like LDN as long as the prescribing falls within the agreed scope of practice 4.

You do not need a specialist referral. Primary care providers, pain management doctors, rheumatologists, and integrative medicine practitioners all prescribe LDN. The deciding factor is usually whether the clinician is familiar with the drug's off-label evidence base.

Some patients report difficulty finding a local prescriber who is willing to write for LDN. This is not a legal barrier. It is a familiarity barrier. Telehealth has largely solved this problem.

Telehealth Prescribing: The Fastest Route for SC Residents

South Carolina permits telehealth prescribing for non-controlled substances. Naltrexone at any dose is not a controlled substance under federal or South Carolina state law 1. This means a provider licensed in SC can evaluate you via video visit and send an LDN prescription directly to a compounding pharmacy the same day.

The typical telehealth workflow looks like this. You complete an intake form and upload recent labs. A clinician reviews your history and conducts a synchronous video or audio visit. If LDN is appropriate, the prescription is transmitted electronically to a 503A compounding pharmacy, either one in South Carolina or one licensed to ship into the state.

Turnaround from visit to prescription transmission is often same-day. The pharmacy then compounds and ships your medication, which adds 3 to 7 business days depending on the pharmacy's workload and shipping method.

Telehealth also removes geographic constraints. Patients in rural parts of the state, from Oconee County to Jasper County, have the same access as someone in Charleston or Columbia. A 2021 analysis in the Journal of General Internal Medicine found that telehealth visits for chronic pain management had equivalent patient satisfaction and clinical outcomes compared to in-person encounters 5.

What Labs Should You Get Before Starting LDN?

Most prescribers require baseline labs before initiating LDN. The standard panel includes a complete blood count (CBC), comprehensive metabolic panel (CMP), and liver function tests (ALT, AST, bilirubin). Naltrexone carries an FDA boxed warning for hepatotoxicity at the full 50 mg dose 1, so liver enzymes are checked before starting and periodically during treatment even though hepatic risk at 1.5 to 4.5 mg appears minimal.

A thyroid panel (TSH, free T4) may be requested if the prescriber suspects autoimmune thyroiditis as part of the clinical picture. Inflammatory markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are sometimes ordered to establish a baseline for tracking treatment response, particularly in autoimmune conditions 6.

If you already have labs from the past 60 to 90 days, most telehealth providers will accept those. You do not necessarily need to repeat bloodwork. Quest Diagnostics and Labcorp both have draw sites throughout South Carolina, and many providers can order labs electronically before your first visit to speed up the process.

How 503A Compounding Pharmacies Work in South Carolina

A 503A pharmacy compounds medications on a patient-specific basis, meaning each prescription is filled for a named individual. South Carolina's Board of Pharmacy oversees these facilities, and they must comply with state compounding regulations and federal USP <795> standards for non-sterile preparations 3.

Several 503A pharmacies operate within South Carolina. Others are located out of state but hold the necessary licenses to ship compounded medications to SC residents. Your prescriber will typically have a preferred pharmacy relationship, but you have the right to choose any licensed compounding pharmacy.

When selecting a pharmacy, confirm three things. First, verify that the pharmacy is licensed in South Carolina or holds a non-resident pharmacy license allowing shipment into the state. Second, ask whether they compound naltrexone capsules (some pharmacies only compound topical or injectable formulations). Third, ask about turnaround time. Most pharmacies fill LDN prescriptions within 2 to 5 business days after receiving the prescription.

Pricing typically ranges from $30 to $60 for a 30-day supply, depending on the dose and the pharmacy. Some pharmacies offer 90-day supplies at a discount.

Cost and Insurance Coverage in South Carolina

LDN is not covered by South Carolina Medicaid. Most commercial insurance plans also do not cover compounded LDN because the indication is off-label and the medication is not commercially manufactured at low doses.

The practical result: most South Carolina patients pay cash. At $30 to $60 per month from a 503A pharmacy, LDN is among the more affordable chronic-use medications. For comparison, pregabalin (Lyrica) for fibromyalgia can cost over $500 per month without insurance 7.

Some patients attempt to use GoodRx or similar discount cards for the 50 mg tablet and then split or dissolve it at home. This approach is discouraged. Dose accuracy matters with LDN. A 2014 review in Medical Hypotheses noted that the therapeutic window for LDN's immunomodulatory effects appears narrow, and patient-prepared dilutions introduce unacceptable variability 8.

If your commercial insurer denies coverage, you may file a prior authorization request. Documentation typically requires the prescribing clinician to provide a letter of medical necessity, evidence of failed first-line therapies, and supporting literature. Approval rates are low, but not zero.

The Evidence Base for LDN: What the Research Shows

Younger et al. published the first pilot crossover trial of LDN for fibromyalgia in 2009. In 10 women with fibromyalgia, LDN 4.5 mg reduced pain scores by 32.5% compared to placebo (P <0.01) over 14 weeks 2. The same group followed up with a larger single-blind trial in 2013 (N=31) that confirmed a 28.8% reduction in pain severity 9.

A 2022 systematic review and meta-analysis published in the Journal of Clinical Medicine pooled data from 10 randomized controlled trials covering fibromyalgia, Crohn's disease, and multiple sclerosis. The authors concluded that LDN showed "a statistically significant improvement in quality of life measures" but called for larger, multi-center RCTs 10.

For Crohn's disease specifically, Smith et al. (2011) randomized 40 patients to LDN 4.5 mg or placebo for 12 weeks. The LDN group showed a 67% response rate (defined by a 70-point drop in Crohn's Disease Activity Index) versus 33% in the placebo arm 11.

Dr. Jarred Younger, who led much of the early fibromyalgia research at Stanford and later at the University of Alabama at Birmingham, has stated: "The mechanism appears to involve a brief blockade of the mu-opioid receptor that leads to a rebound increase in endogenous opioid tone, combined with direct anti-inflammatory effects on microglia" 2.

The Endocrine Society has not issued formal guidelines on LDN. The American Academy of Pain Medicine includes naltrexone in its educational materials on multimodal pain management but stops short of a clinical practice recommendation 12.

These gaps in guideline coverage are why most insurers classify LDN as investigational. The evidence is promising but still building.

How to Start: Step-by-Step for South Carolina Residents

Here is the actual sequence from deciding to try LDN to receiving your first bottle.

Step 1: Get baseline labs. Order a CBC, CMP, and liver function panel through your PCP, a walk-in lab, or a telehealth provider who can send a lab order to a Quest or Labcorp location near you.

Step 2: Schedule a visit. Book a telehealth or in-person appointment with a provider who prescribes LDN. If using telehealth, confirm the provider holds a South Carolina license.

Step 3: Clinical evaluation. The provider reviews your labs, medical history, current medications (especially opioids, which are a contraindication), and determines whether LDN is appropriate. Expect the visit to take 15 to 30 minutes.

Step 4: Prescription transmission. If approved, the provider sends your prescription electronically to a 503A compounding pharmacy. Most prescribers start at 1.5 mg nightly for the first two weeks, then titrate up to 3 mg, and finally to 4.5 mg over four to six weeks.

Step 5: Pharmacy fulfillment. The compounding pharmacy prepares your capsules and ships them. Expect delivery within 3 to 7 business days.

Step 6: Follow-up. Most providers schedule a follow-up at 8 to 12 weeks to assess symptom response, side effects, and lab values. Common early side effects include vivid dreams and mild headache, both of which typically resolve within one to two weeks 2.

Transferring an LDN Prescription to South Carolina

If you already have an LDN prescription from a provider in another state, you have two options. You can ask your current provider to send the prescription to a South Carolina-licensed compounding pharmacy directly. Most 503A pharmacies accept out-of-state prescriptions as long as the prescriber is licensed in their own state and the pharmacy is licensed to dispense to SC residents.

Alternatively, if your current provider is not licensed in South Carolina and you want ongoing care, you will need to establish with a new SC-licensed provider. Your current provider can send medical records and the existing prescription history to simplify the new evaluation.

South Carolina does not impose a waiting period or special transfer protocol for non-controlled compounded medications. The bottleneck is usually the prescriber-pharmacy relationship, not state regulation.

Contraindications and Drug Interactions

LDN is contraindicated in patients currently taking opioid medications, including tramadol, codeine, oxycodone, and hydrocodone. Even low-dose naltrexone can precipitate acute opioid withdrawal. The FDA label for naltrexone 50 mg recommends a 7-to-10-day opioid-free window before initiation 1. Most LDN prescribers apply the same washout period.

Patients on immunosuppressive therapy should discuss LDN with their prescriber, as LDN's proposed mechanism involves immune modulation. There is no published evidence of dangerous interactions between LDN and methotrexate or biologics, but the theoretical concern warrants clinical discussion 10.

Alcohol use is not an absolute contraindication at low doses, but patients should be aware that naltrexone may reduce the subjective pleasure from alcohol, which is the basis of its FDA-approved use at 50 mg.

Hepatic impairment requires caution. Check baseline liver enzymes before starting and repeat them at 12 weeks 1.